Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology

Journal of Biomolecular Screening

Volumn 11, Issue 4, 2006, Pages 359-368

  Perrin, Dominique ^a   Frémaux, Christéle ^a   Scheer, Alexander ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

Electrophoresis; Kinase; Mobility shift; Nanofluidics; Screening

Indexed keywords

NANOPARTICLE; PROTEIN SERINE THREONINE KINASE;

ACCURACY; ARTICLE; ELECTROPHORESIS; ENZYME ASSAY; ENZYME SUBSTRATE; FILTRATION; FLUORESCENCE; INCUBATION TIME; INTERMETHOD COMPARISON; LIQUID; MICROCHIP ANALYSIS; MOBILITY SHIFT ASSAY; PIPETTE; PRIORITY JOURNAL; SCREENING; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; VALIDATION PROCESS;

DRUG EVALUATION, PRECLINICAL; ELECTROPHORESIS, MICROCHIP; KINETICS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PROTEIN-SERINE-THREONINE KINASES; REPRODUCIBILITY OF RESULTS;

EID: 33744944817     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057106286653     Document Type: Article

References (23)

1. Vlahos CJ, McDowell SA, Clerck A: Kinases as therapeutic targets for heart failure. Nat Rev Drug Disc 2003;2:99-113.
2. Fabbro D, Garcia-Etchevarria C: Targeting protein kinases in cancer therapy. Curr Opin Drug Discov Devel 2002;5:701-712.
3. Orchard S: Kinases as targets: prospects for chronic therapy. Curr Opin Drug Discov Devel 2002;5:713-717.
4. Vieth M, Sutherland JJ, Robertson DH, Campbell RM: Kinomics: characterizing the therapeutically validated kinase space. Drug Discov Today 2005;10:839-846.
5. Manley PW, Cowan-Jacob SW, Buchdunger E, Fabbro D, Fendrich G, Furet P, et al: Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer 2002;38:S19-S27.
6. Cohen P: Protein kinases: the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1:309-315.
7. Park YW, Cummings RT, Wu L, Zheng S, Cameron PM, Woods A, et al: Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104.
8. Pommereau A, Everard P, Kannt A: Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format. J Biomol Screen 2004;9:409-416.
9. Von Leoprechting A, Kumpf R, Menzel S, Reulle D, Griebel R, Valler MJ, et al: Miniaturization and validation of a high-throughput serine kinase assay using the Alpha Screen platform. J Biomol Screen 2004;9:719-725.
10. Parker GJ, Law TL, Lenoch FJ, Bolger RE: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand- binding and kinase/phosphatase assays. J Biomol Screen 2000;5:77-88.
11. Zaman GJR, Garritsen A, de Boer T, van Boeckel CAA: Homogeneous assays for adenosine 5′-monophosphate-activated protein kinase. Comb Chem High Throughput Screen 2003;6:313-320.
12. Gaudet EA, Huang KS, Zhang Y, Huang W, Mark D, Sportsman JR: A homogeneous fluorescence polarization assay adaptable for a range of serine/threonine and tyrosine kinases. J Biomol Screen 2003;8:164-175.
13. Li Y, Cummings RT, Cunningham BR, Chen Y, Zhou G: Homogeneous assays for adenosine 5′-monophosphate-activated protein kinase. Anal Biochem 2003;321:151-156.
14. Loomans EEMG, van Doormalen AM, Wat JWY, Zaman GJR: High-throughput screening with immobilized metal ion affinity based fluorescence polarization detection, a homogeneous assay for protein kinases. Assay Drug Dev Technol 2003;1:455-459.
15. Pope AJ: Introduction LANCE™ vs. HTRF® technologies (or vice versa). J Biomol Screen 1999;4:301-302.
16. Ohml N, Wingfield JM, Yazawa H, Inagaki O: Development of a homogeneous time-resolved fluorescence assay for high throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. J Biomol Screen 2000;5:463-470.
17. Wu G, Irvine J, Luft C, Pressley D, Hodge CN, Janzen B: Assay development and high throughput screening of caspases in microfluidic format. Comb Chem High Throughput Screen 2003;6:303-312.
18. Fabian MA, Biggs WH III, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, et al: A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 2005;3:308-309.
19. Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J: A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). J Biomol Screen 2002;7:507-514.
20. Merlot C, Domine D, Cleva C, Church DJ: Chemical substructures in drug discovery. Drug Discov Today 2003;8:594-602.
21. Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
22. Dunne J, Reardon H, Trinh V, Ella L, Farinas J: Comparison of on-chip and off-chip microfluidic kinase assay formats. Assay Drug Devel Technol 2004;2:121-129.
23. Sills MA, Weiss D, Pham Q, Schweitzer R, Wu X, Wu JJ: Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J Biomol Screen 2002;7:191-214.